Palisade Bio Inc (PALI)
6.70
-1.16
(-14.76%)
USD |
NASDAQ |
May 08, 16:00
7.45
+0.75
(+11.19%)
After-Hours: 19:37
Palisade Bio Total Assets (Quarterly): 14.05M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.05M |
| September 30, 2023 | 17.07M |
| June 30, 2023 | 18.29M |
| March 31, 2023 | 15.26M |
| December 31, 2022 | 15.76M |
| September 30, 2022 | 16.27M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.806M |
| March 31, 2022 | 8.35M |
| December 31, 2021 | 12.51M |
| September 30, 2021 | 16.27M |
| June 30, 2021 | 14.95M |
| December 31, 2020 | 3.019M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.019M
Minimum
Dec 2020
18.29M
Maximum
Jun 2023
13.30M
Average
15.11M
Median
Total Assets (Quarterly) Benchmarks
| TG Therapeutics Inc | 373.32M |
| Protagenic Therapeutics Inc | 4.323M |
| Bio-Path Holdings Inc | 3.22M |
| Jaguar Health Inc | 50.76M |
| Finch Therapeutics Group Inc | 55.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.739M |
| Shareholders Equity (Quarterly) | 11.31M |